Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-31 1:58 pm Purchase | 2022-12-31 | 13G | NovoCure Limited NVCR | BlackRock Inc. BLK | 7,605,425 7.200% | 916,069 (+13.69%) | Filing |
| 2023-01-23 10:49 am Sale | 2022-12-30 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 8,863,842 8.450% | -751,326 (-7.81%) | Filing History |
| 2022-04-11 09:01 am Purchase | 2022-04-08 | 13G | NovoCure Limited NVCR | FMR LLC | 10,736,704 10.281% | 2,926,367 (+37.47%) | Filing History |
| 2022-02-11 2:48 pm Purchase | 2022-02-14 | 13G | NovoCure Limited NVCR | Capital World Investors | 12,723,214 12.300% | 1,694,783 (+15.37%) | Filing History |
| 2022-02-11 11:19 am Purchase | 2022-02-14 | 13G | NovoCure Limited NVCR | Capital International Investors | 11,531,075 11.100% | 822,013 (+7.68%) | Filing History |
| 2022-02-10 08:27 am Sale | 2021-12-31 | 13G | NovoCure Limited NVCR | The Vanguard Group | 7,893,313 7.600% | -350,657 (-4.25%) | Filing History |
| 2022-02-09 09:22 am Sale | 2022-02-08 | 13G | NovoCure Limited NVCR | FMR LLC | 7,810,337 7.522% | -1,835,049 (-19.03%) | Filing History |
| 2022-02-03 4:41 pm Purchase | 2021-12-31 | 13G | NovoCure Limited NVCR | BlackRock Inc. BLK | 6,689,356 6.400% | 892,675 (+15.40%) | Filing |
| 2022-01-26 09:17 am Purchase | 2021-12-31 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 9,615,168 9.260% | 1,354,093 (+16.39%) | Filing History |
| 2021-08-10 12:28 pm Purchase | 2021-08-10 | 13G | NovoCure Limited NVCR | Capital International Investors | 10,709,062 10.300% | 2,271,587 (+26.92%) | Filing History |
| 2021-05-10 12:49 pm Purchase | 2021-05-10 | 13G | NovoCure Limited NVCR | Capital World Investors | 11,028,431 10.700% | 3,272,161 (+42.19%) | Filing History |
| 2021-02-16 1:57 pm Purchase | 2021-02-16 | 13G | NovoCure Limited NVCR | Capital International Investors | 8,437,475 8.300% | 8,437,475 (New Position) | Filing History |
| 2021-02-16 12:14 pm Purchase | 2021-02-16 | 13G | NovoCure Limited NVCR | Capital World Investors | 7,756,270 7.600% | 7,756,270 (New Position) | Filing History |
| 2021-02-10 11:40 am Purchase | 2020-12-31 | 13G | NovoCure Limited NVCR | The Vanguard Group | 8,243,970 8.100% | 990,600 (+13.66%) | Filing History |
| 2021-02-08 10:29 am Sale | 2021-02-05 | 13G | NovoCure Limited NVCR | FMR LLC | 9,645,386 9.473% | -2,534,042 (-20.81%) | Filing History |
| 2021-02-05 08:03 am Purchase | 2020-12-31 | 13G | NovoCure Limited NVCR | BlackRock Inc. BLK | 5,796,681 5.700% | 1,496,934 (+34.81%) | Filing |
| 2021-02-01 12:08 pm Sale | 2020-12-31 | 13G | NovoCure Limited NVCR | Wyss Hansjoerg | 8,141,397 8.000% | -813,351 (-9.08%) | Filing History |
| 2021-01-14 12:14 pm Purchase | 2020-12-31 | 13G | NovoCure Limited NVCR | BAILLIE GIFFORD & CO | 8,261,075 8.120% | 252,093 (+3.15%) | Filing History |
| 2020-12-21 4:02 pm Sale | 2020-12-02 | 13D | NovoCure Limited NVCR | Perlhagen Gert L. | 4,829,200 4.740% | -1,170,800 (-19.51%) | Filing History |